risankizumab,ustekinumab,vedolizumab
abbvie,janssen,takeda
[]
 secondary nr or partial nr definitely as to primary nr, at that point we are often desperate for effective medication and so would consider but share the decision with the patient
#IBD Doctor. Promoting science in medicine, listening to patients and lowering cost of care.
I collect titles, but just call me Jason